Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.2
92.67%
40%
—
87.29%
60%
—
5 Years
Score5.2
Net Growth92.67%
Net Trend40%
Net Income Consistency—
Rev Growth87.29%
Rev Trend60%
Revenue Consistency—
PTC Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 380M to $ 1.73B and net income went from -$ 438M to $ 682M. Revenue increased in 3 of those 5 years; net income in 2.
Between 2015 and 2025, revenue grew from $ 36M to $ 1.73B and net income went from -$ 170M to $ 682M. Revenue increased in 8 of those 10 years; net income in 3.
PTC Therapeutics Inc currently holds a 5-year HDB Score of 5.2 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 72.64 | — |
1 Year2025-08-12 | $ 45.27 | 60.46% |
5 Years2021-08-12 | $ 39.97 | 81.74% |
10 Years2016-08-12 | $ 8.12 | 8x |
All Time2013-06-20 | $ 16.49 | 340.51% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2013-06-20 |
|---|---|---|---|---|---|
| Price | $ 72.64 | $ 45.27 | $ 39.97 | $ 8.12 | $ 16.49 |
| Return | — | 60.46% | 81.74% | 8x | 340.51% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1.00B | -$ 38M | $ 2.22B |
| 2025 | $ 1.73B | $ 682M | $ 1.94B |
| 2024 | $ 806M | -$ 363M | $ 1.13B |
| 2023 | $ 937M | -$ 626M | $ 876M |
| 2022 | $ 698M | -$ 559M | $ 410M |
| 2021 | $ 538M | -$ 523M | $ 773M |
| 2020 | $ 380M | -$ 438M | $ 1.10B |
| 2019 | $ 306M | -$ 251M | $ 686M |
| 2018 | $ 264M | -$ 128M | $ 227M |
| 2017 | $ 194M | -$ 79M | $ 191M |
| 2016 | $ 82M | -$ 142M | $ 231M |
| 2015 | $ 36M | -$ 170M | $ 338M |
| 2014 | $ 22M | -$ 93M | $ 315M |
| IPO2013 | $ 31M | -$ 51M | $ 142M |
Explore beyond PTCT
You're looking at PTC Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
